Patents by Inventor Xudong Geng

Xudong Geng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gp120 specific antigens and uses thereof
    Patent number: 7531181
    Abstract: The present invention provides multi-antigenic constructs comprising one or more carbohydrate antigens having the formula: wherein R1, R2A, R2B, R3, R4, W1, W2 and W3 are as defined herein; and additionally provides compositions thereof, and methods for their use in the treatment and/or prevention of HIV infection, and methods for inducing HIV-specific antibodies in a subject, comprising administering to a subject in need thereof, an effective amount of any of the inventive compounds as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier. In another aspect, the invention provides an antibody or antibody fragment which binds specifically to a gp120 glycan or glycopeptide of the invention.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: May 12, 2009
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Samuel J. Danishefsky, Vadim Dudkin, Xudong Geng, Mihirbaran Mandal, Isaac Kraus
  • Novel Macrocycles and Uses Thereof
    Publication number: 20080108694
    Abstract: The present invention relates to compounds having the structure (and pharmaceutically acceptable derivatives thereof) wherein Ro-R4, Z, X, A-B, D-E, G-J, and K-L are as defined herein, the synthesis thereof and the use of these compounds as therapeutic agents.
    Type: Application
    Filed: December 17, 2004
    Publication date: May 8, 2008
    Inventors: Samuel J Danishefsky, Zhi-Qiang Yang, Xudong Geng, Ting-Chao Chou, Neal Rosen
  • Gp120 specific antigens and uses thereof
    Publication number: 20060229432
    Abstract: The present invention provides multi-antigenic constructs comprising one or more carbohydrate antigens having the formula: wherein R1, R2A, R2B, R3, R4, W1, W2 and W3 are as defined herein; and additionally provides compositions thereof, and methods for their use in the treatment and/or prevention of HIV infection, and methods for inducing HIV-specific antibodies in a subject, comprising administering to a subject in need thereof, an effective amount of any of the inventive compounds as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier. In another aspect, the invention provides an antibody or antibody fragment which binds specifically to a gp120 glycan or glycopeptide of the invention.
    Type: Application
    Filed: June 3, 2005
    Publication date: October 12, 2006
    Inventors: Samuel Danishefsky, Vadim Dudkin, Xudong Geng, Mihirbaran Mandal, Isaac Kraus